Patient Gateway

RSS Feed

REZILIENT3: First-Line Zipalertinib Plus Chemotherapy in EGFR Exon 20 NSCLC

从循证获益到规范实践：EGFR 突变可切除 NSCLC 术后辅助治疗全程管理要点_腾讯新闻

Case Report: Durable complete response to dual immune checkpoint blockade and EGFR inhibition in microsatellite-stable metastatic duodenal adenocarcinoma

Seqera’s Small-Model Approach Tops EGFR Binding Benchmark

HERON-Lung01: HER3-Directed ADC Prolongs Progression-Free Survival in EGFR-Mutated Advanced NSCLC

Osimertinib Plus Savolitinib in EGFR-Mutated NSCLC After Disease Progression

2026 ESMO | PACE-LUNG研究：ctDNA动态监测指导EGFR突变晚期NSCLC一线联合升阶的可行性验证_腾讯新闻

Case Report: Longitudinal clonal evolution in EGFR-mutant lung adenocarcinoma with coexisting MET exon 14 skipping and EML4-ALK fusion and subsequent KRAS/BRAF bypass mutations

Case Report: Long-term survival of a patient with lung adenocarcinoma harboring EGFR 19del/T790M/C797S and KIF26B-NTRK1 rearrangement

RHBDL2 promotes cancer stemness and chemoresistance in triple-negative breast cancer through EGFR/PI3K/AKT/mTOR/c-Myc pathway